Form 4 for BIO BIO-RAD LABORATORIES, INC.

Accepted 2022-09-06 00:00:00 ET · period of report 2022-09-01 · accession 0001062993-22-019183 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-09-06	2022-09-01	BIO	Daskal Ilan	EVP, CFO	M - OptEx	$0.00	+455	907	+101%	$0
D	2022-09-06	2022-09-01	BIO	Daskal Ilan	EVP, CFO	F - Tax	$486.25	-226	681	-25%	-$109.9K
D	2022-09-06	2022-09-01	BIO	Daskal Ilan	EVP, CFO	M - OptEx	$0.00	-455	1,368	-25%	$0
D	2022-09-06	2022-09-01	BIO	Daskal Ilan	EVP, CFO	A - Grant	$0.00	+2,776	2,776	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Bio-Rad A Common Stock	2022-09-01	M	A	455	$0.00	907	D	—	—	(F1) Shares of Class A common stock acquired on the vesting of restricted stock units.
2	Common	Bio-Rad A Common Stock	2022-09-01	F	D	226	$486.25	681	D	—	—
3	Derivative	Restricted Stock Units	2022-09-01	M	D	455	$0.00	1,368	D	$0.00 · — to —	455 Bio-Rad A Common Stock	(F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F4) On September 1, 2021, the reporting person was granted 1,823 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
4	Derivative	Restricted Stock Units	2022-09-01	A	A	2,776	$0.00	2,776	D	$0.00 · — to —	2,776 Bio-Rad A Common Stock	(F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F3) The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.